Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign prostatic hyperplasia (BPH). Millions of patients do not see effective relief from drugs, yet decline to undergo an invasive surgical procedure with high risk of side effects such as sexual dysfunction. To meet this clinical need, Zenflow has developed the Spring System. The device is designed to be deployed in the urologist's office in a simple, atraumatic procedure. Ongoing clinical trials have shown positive results out to four years after treatment.

Medical Devices

Zenflow

Nick Damiano

Erica Lindquist, BSN, RN, CNOR

Sierra Yearsley

Shreya Ramesh

Jamey Nielsen

Brenton Huang

Shreya Mehta

Ronald Jabba

The Research and Development Team at Zenflow focuses on innovating and enhancing medical devices aimed at alleviating urinary obstruction due to benign prostatic hyperplasia (BPH). This team spearheads the design, testing, and clinical evaluation of the Spring System, ensuring its effectiveness and safety through rigorous trials. By collaborating with clinical specialists and analyzing data, they drive continuous improvements and help translate research insights into practical solutions for urologists and patients.

Research and Development Team

Leadership Team

Research and Development Team

About

Team members

Other teams at Zenflow

Leadership Team